General In Vitro Diagnostics Market Research Reports & Industry Analysis
General In Vitro Diagnostics Industry Research & Market Reports
-
Carrier Screening
... CAGR of 15.6% over the analysis period 2024-2030. Molecular Screening Test, one of the segments analyzed in the report, is expected to record a 17.4% CAGR and reach US$5.5 Billion by the end of the ... Read More
-
Arbovirus Testing
... CAGR of 5.9% over the analysis period 2024-2030. ELISA-based Tests, one of the segments analyzed in the report, is expected to record a 5.5% CAGR and reach US$1.0 Billion by the end of the analysis ... Read More
-
Oxidative Stress Assays
... at a CAGR of 8.4% over the analysis period 2024-2030. Oxidative Stress Assays Consumables, one of the segments analyzed in the report, is expected to record a 9.2% CAGR and reach US$1.3 Billion by the ... Read More
-
Malaria Diagnostics
... CAGR of 5.6% over the analysis period 2024-2030. Rapid Diagnostic Tests, one of the segments analyzed in the report, is expected to record a 5.7% CAGR and reach US$685.9 Million by the end of the ... Read More
-
Paper Diagnostics
... CAGR of 6.6% over the analysis period 2024-2030. Lateral Flow Assay Kits, one of the segments analyzed in the report, is expected to record a 6.2% CAGR and reach US$6.7 Billion by the end of ... Read More
-
Medical Device Market Medical Device Market by Device Type, Function, Durability, Therapeutic Segment, Risk Classification, Manufacture Method, Delivery/Acquisition, Operational Support Model, Connectivity and Region 2025 – 2030
... (hospital, home, clinic, etc.), function (critical care, diagnostic, dental, etc.), durability, risk classification, manufacturing method (traditional vs. 3D printed), delivery/acquisition method, operational support model, and connectivity (Bluetooth, cellular, Wi-Fi, etc.). It also examines the therapeutic ... Read More
-
Thyroid Function Tests
... at a CAGR of 4.0% over the analysis period 2024-2030. TSH Tests, one of the segments analyzed in the report, is expected to record a 4.0% CAGR and reach US$1.2 Billion by the end of ... Read More
-
Chlamydia Infection Diagnostics and Therapeutics
... Billion by 2030, growing at a CAGR of 4.8% over the analysis period 2024-2030. Chlamydia Infection Diagnostics, one of the segments analyzed in the report, is expected to record a 5.1% CAGR and reach US$1.6 ... Read More
-
Glucose Biosensors
... CAGR of 2.1% over the analysis period 2024-2030. Hospitals End-Use, one of the segments analyzed in the report, is expected to record a 1.8% CAGR and reach US$1.5 Billion by the end of the analysis ... Read More
-
Artificial Intelligence (AI) in Medical Diagnostics
... reach US$4.4 Billion by 2030, growing at a CAGR of 22.2% over the analysis period 2024-2030. AI Software, one of the segments analyzed in the report, is expected to record a 24.0% CAGR and reach ... Read More
-
Clinical Risk Grouping Solutions
... 2030, growing at a CAGR of 13.8% over the analysis period 2024-2030. Scorecard & Visualization Tools, one of the segments analyzed in the report, is expected to record a 15.1% CAGR and reach US$1.1 Billion ... Read More
-
Predictive and Presymptomatic Testing
... 2030, growing at a CAGR of 9.5% over the analysis period 2024-2030. The U.S. Market is Estimated at US$1.6 Billion While China is Forecast to Grow at 12.7% CAGR The Predictive and Presymptomatic Testing market ... Read More
-
Sepsis Diagnostics
... CAGR of 7.5% over the analysis period 2024-2030. Microbiology Technology, one of the segments analyzed in the report, is expected to record a 9.1% CAGR and reach US$749.8 Million by the end of the analysis ... Read More
-
Pregnancy Detection Kits
... at a CAGR of 4.8% over the analysis period 2024-2030. Home Pregnancy Tests (HPT), one of the segments analyzed in the report, is expected to record a 5.6% CAGR and reach US$805.2 Million by the ... Read More
-
In Vitro Toxicology Testing
... 2030, growing at a CAGR of 8.8% over the analysis period 2024-2030. Cell Culture Technology, one of the segments analyzed in the report, is expected to record a 8.2% CAGR and reach US$11.2 Billion by ... Read More
-
C-Reactive Protein Testing
... at a CAGR of 1.7% over the analysis period 2024-2030. Cardiovascular Diseases, one of the segments analyzed in the report, is expected to record a 2.6% CAGR and reach US$1.0 Billion by the end of ... Read More
-
Endocrine Testing
... CAGR of 5.0% over the analysis period 2024-2030. Thyroid Stimulating Hormone (TSH) Testing, one of the segments analyzed in the report, is expected to record a 5.5% CAGR and reach US$6.3 Billion by the end ... Read More
-
ATP Assay
... CAGR of 7.1% over the analysis period 2024-2030. ATP Assay Consumables & Accessories, one of the segments analyzed in the report, is expected to record a 6.9% CAGR and reach US$487.0 Million by the end ... Read More
-
Rabies Diagnostics
... CAGR of 5.4% over the analysis period 2024-2030. Fluorescent Antibody Tests (FAT) Method, one of the segments analyzed in the report, is expected to record a 5.2% CAGR and reach US$910.1 Million by the end ... Read More
-
Bio-MEMS
... 16.7% over the analysis period 2024-2030. Microfluidic Chips, one of the segments analyzed in the report, is expected to record a 17.1% CAGR and reach US$27.4 Billion by the end of the analysis period. Growth ... Read More
-
In-Vitro Diagnostics (IVD) Packaging
... 2030, growing at a CAGR of 4.5% over the analysis period 2024-2030. Bottles, one of the segments analyzed in the report, is expected to record a 3.3% CAGR and reach US$4.0 Billion by the end ... Read More
-
Slide Stainers
... CAGR of 9.5% over the analysis period 2024-2030. Slide Stainer Reagents, one of the segments analyzed in the report, is expected to record a 10.7% CAGR and reach US$6.4 Billion by the end of the ... Read More
-
Bio-MEMS Devices
... CAGR of 16.7% over the analysis period 2024-2030. Implantables, one of the segments analyzed in the report, is expected to record a 15.7% CAGR and reach US$18.2 Billion by the end of the analysis period. ... Read More
-
Anatomic Pathology
... CAGR of 5.8% over the analysis period 2024-2030. Anatomic Pathology Services, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$36.4 Billion by the end of the ... Read More
-
Helicobacter Pylori Diagnostics
... at a CAGR of 4.8% over the analysis period 2024-2030. Invasive Test, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$556.8 Million by the end of ... Read More